Definium Therapeutics, Inc. (DFTX)

CIK 1813814 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Definium Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026SCHEDULE 13G0000315066-26-002739
Sep 29, 202640001104659-26-112065
Sep 29, 202640001104659-26-112061
Sep 29, 202640001104659-26-112058
Sep 29, 202640001104659-26-112060
Sep 29, 202640001104659-26-112062
Sep 25, 20261440001950047-26-009823
Sep 25, 20261440001950047-26-009816
Sep 25, 20261440001950047-26-009813
Sep 25, 20261440001950047-26-009814
Sep 25, 20261440001950047-26-009817
Sep 18, 202640001193125-26-395893
Sep 18, 202640001193125-26-395892
Sep 14, 202640001193125-26-389887
Sep 14, 20268-K0001104659-26-107275
Sep 14, 202640001193125-26-389892
Sep 14, 202640001193125-26-389889
Sep 14, 202640001193125-26-389888
Sep 14, 202640001193125-26-389890
Sep 8, 20268-K0001193125-26-384403
Sep 4, 202640001193125-26-384042
Sep 3, 20261440001950047-26-009064
Aug 14, 2026SCHEDULE 13G/A0000938206-26-000039
Aug 14, 2026SCHEDULE 13G/A0001831942-26-000034
Aug 12, 202640001193125-26-345835